LBO — NORTHEAST GEORGIA MEDICAL CENTER
IRR: 23.5% | MOIC: 2.87x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
23.5%
IRR
2.87x
MOIC
$703.6M
Entry EV
$1.4B
Exit EV
$362.0M
Equity Invested
Sources & Uses
S&UTotal · $703.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $273.2M | 38.8% | |
| Sub Debt | $68.3M | 9.7% | |
| Equity | $362.0M | 51.5% | |
| Enterprise Value | $683.1M | 97.1% | |
| Transaction Fees | $20.5M | 2.9% | |
| Total Uses | $703.6M | 100.0% |
Interpretation
INTAt 2.87x MOIC and 23.5% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $130.2M |
| Exit Ev | $1.4B |
| Net Debt At Exit | $327.7M |
| Equity At Exit | $1.0B |
| Equity Invested | $362.0M |
| Total Value Created | $677.6M |
| Value From Growth | $650.1M |
| Value From Multiple | $34.2M |
| Value From Deleveraging | $13.9M |